tiprankstipranks
Trending News
More News >
Oncopeptides AB (SE:ONCO)
:ONCO
Sweden Market

Oncopeptides AB (ONCO) Cash flow

Compare
8 Followers

Oncopeptides AB Cash Flow

SE:ONCO's free cash flow for Q2 2025 was kr-54.41M. For the 2025 fiscal year, SE:ONCO's free cash flow was decreased by kr19.04M and operating cash flow was kr-54.41M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
kr -260.57Mkr -279.49Mkr -420.51Mkr -1.52Bkr -1.30B
Investing Cash Flow
kr 496.00Kkr -116.00Kkr -2.51Mkr -339.00Kkr -20.13M
Financing Cash Flow
kr 263.81Mkr 106.89Mkr 392.40Mkr 1.03Bkr 1.32B
End Cash Position
kr 178.54Mkr 173.41Mkr 344.51Mkr 362.19Mkr 840.25M
Free Cash Flow
kr -260.57Mkr -279.61Mkr -423.02Mkr -1.52Bkr -1.31B
Currency in SEK

Oncopeptides AB Cash Flow